Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TTV | Ann: December Quarter 12 Appendix 4C | 13:09 | 0 | 716 | |||
|
|||||||
TTV | Ann: Letter to Shareholders | 29/01/13 | 0 | 714 | |||
|
|||||||
TTV | Ann: Closure of Share Offer | 25/01/13 | 0 | 606 | |||
|
|||||||
TTV | Ann: Revised Prospectus Timetable | 16/01/13 | 0 | 668 | |||
|
|||||||
TTV | Ann: Appendix 3B | 16/01/13 | 0 | 586 | |||
|
|||||||
TTV | Ann: Change of Director's Interest Notice | 16/01/13 | 0 | 518 | |||
|
|||||||
TTV | Ann: Update on Appendix 3B | 24/12/12 | 0 | 427 | |||
|
|||||||
TTV | Ann: Letter to Ineligible Shareholders (Bonus Off | 20/12/12 | 0 | 469 | |||
|
See All Discussions